{"id":5220,"date":"2022-03-16T11:51:30","date_gmt":"2022-03-16T11:51:30","guid":{"rendered":"https:\/\/www.nfp-drugs.bg\/en\/?p=5220"},"modified":"2022-09-01T12:17:06","modified_gmt":"2022-09-01T12:17:06","slug":"issue-8-of-news-bulletin-for-the-new-psychoactive-substances","status":"publish","type":"post","link":"https:\/\/www.nfp-drugs.bg\/en\/issue-8-of-news-bulletin-for-the-new-psychoactive-substances\/","title":{"rendered":"Issue 8 of NEWS bulletin for the new psychoactive substances"},"content":{"rendered":"\n<p>In issue 8 of the edition of the National Focal Point on Drugs and Drug Addictions NEWS &#8211; Bulletin for the new psychoactive substances you will find the following topics:<\/p>\n\n\n\n<ul><li>New psychoactive substances identified in Bulgaria in 2021.<\/li><li>New psychoactive substances established for the first time on the territory of Bulgaria in 2021.<\/li><li>New psychoactive substances placed under control in Bulgaria in 2022.<\/li><li>New psychoactive substances identified in Europe in 2021.<\/li><li>Focus on 3-CMC.<\/li><li>Fake Percoset tablets containing etonitazepine.<\/li><li>&#8220;Nice Guy&#8221; &#8211; smoking mixtures.<\/li><li>Inclusion of MDA in the list of substances of high concern.<\/li><li>Cannabis mixed with synthetic cannabinoids.<\/li><li>Edibles containing THC and the risks associated with them.<\/li><\/ul>\n\n\n\n<p><a href=\"https:\/\/www.nfp-drugs.bg\/wp-content\/uploads\/2022\/09\/NEWS_8.pdf\">Issue 8 of NEWS (in Bulgarian)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In issue 8 of the edition of the National Focal Point on Drugs and Drug Addictions NEWS &#8211; Bulletin for the new psychoactive substances you will find the following topics: New psychoactive substances identified in Bulgaria in 2021. New psychoactive substances established for the first time on the territory of Bulgaria in 2021. New psychoactive [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5221,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[70,54,69],"_links":{"self":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/5220"}],"collection":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/comments?post=5220"}],"version-history":[{"count":3,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/5220\/revisions"}],"predecessor-version":[{"id":5249,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/5220\/revisions\/5249"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/media\/5221"}],"wp:attachment":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/media?parent=5220"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/categories?post=5220"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/tags?post=5220"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}